Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria

Carbohydrate Research

Volumn 342, Issue 12-13, 2007, Pages 1773-1780

  Davis, Chris B ^a   Hartnell, Regan D ^a   Madge, Paul D ^a   Owen, David J ^a   Thomson, Robin J ^a   Chong, Andrew K J ^a   Coppel, Ross L ^b   Von Itzstein, Mark ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Galactofuranose; Inhibition; Mycobacterium; Mycobacterium smegmatis; Sulfone; Thioglycoside

Indexed keywords

GALACTOFURANOSE; LEWIS ACID; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; SULFONE; THIOGLYCOSIDE;

BACTERIA; CATALYSIS; CELL GROWTH; CELL MEMBRANES; DERIVATIVES;

SUGARS;

1,2,3,5,6 PENTA O ACYL DEXTRO GALACTOFURANOSE; 9 HEPTA SULFONE; AGLYCONE; ANTIINFECTIVE AGENT; GALACTOFURANOSE; GALACTOFURANOSYL ALKYL THIOGLYCOSIDE; GALACTOSE; LEWIS ACID; THIOGLYCOSIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; CATALYSIS; DRUG INHIBITION; DRUG SYNTHESIS; GLYCOSIDATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTITUBERCULAR AGENTS; GALACTOSE; INDICATORS AND REAGENTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYCOBACTERIUM; SULFONES; THERMODYNAMICS; THIOGLYCOSIDES;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS;

EID: 34447321847     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carres.2007.04.027     Document Type: Article

References (20)

1. World Health Organisation, World Health Report, 2004.
2. In: Bastian I., and Portaels F. (Eds). Multidrug-resistant Tuberculosis (2000), Kluwer Academic, Dordrecht
3. Stokstad E. Science 287 (2000) 2391
4. Daffe M., Brennan P.J., and McNeil M. J. Biol. Chem. 265 (1990) 6734-6743
5. Owen D.J., Davis C.B., Hartnell R.D., Madge P.D., Thomson R.J., Chong A.K.J., Coppel R., and von Itzstein M. Bioorg. Med. Chem. Lett. 17 (2007) 2274-2277
6. Witczak Z. Curr. Med. Chem. 6 (1999) 165-178
7. Driguez H. ChemBioChem 2 (2001) 311-318
8. Marino C., Marino K., Miletti L., Alves M.J.M., Colli W., and de Lederkremer R.M. Glycobiology 8 (1998) 901-904
9. Bennett S., von Itzstein M., and Kiefel M.J. Carbohydr. Res. 259 (1994) 293-299
10. Park W.K.C., Meunier S.J., Zanini D., and Roy R. Carbohydr. Lett. 1 (1995) 179-184
11. Owen D.J., and von Itzstein M. Carbohydr. Res. 328 (2000) 287-292
12. D'Accorso N.B., Thiel I.M.E., and Schüller M. Carbohydr. Res. 124 (1983) 177-184
13. Velty R., Benvegnu T., Gelin M., Privat E., and Plusquellec D. Carbohydr. Res. 299 (1997) 7-14
14. Chittenden G.J.F. Carbohydr. Res. 25 (1972) 35-41
15. Smith R.V., and Rosazza J.P. Biotechnol. Bioeng. 17 (1975) 785-814
16. Baca A.M., Sirawaraporn R., Turley S., Sirawaraporn W., and Hol W.G.J. J. Mol. Biol. 302 (2000) 1193-1212
17. Mitscher L.A., and Baker W.R. Pure Appl. Chem. 70 (1998) 365-371
18. National Committee for Clinical Laboratory Standards (NCCLS), Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes; Approved Standard, 2003, Document M24-A.
19. National Committee for Clinical Laboratory Standards (NCCLS), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 2003, Document M7-A6.
20. Alcaide F., Pfyffer G.E., and Telenti A. Antimicrob. Agents Chemother. 41 (1997) 2270-2273